STOCK TITAN

Vaccinex, Inc. - $VCNX STOCK NEWS

Welcome to our dedicated page for Vaccinex news (Ticker: $VCNX), a resource for investors and traders seeking the latest updates and insights on Vaccinex stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Vaccinex's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Vaccinex's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.67%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.67%
Tags
conferences
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.38%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-57.59%
Tags
-
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.74%
Tags
management
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.84%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.17%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.9%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.22%
Tags
Vaccinex, Inc.

Nasdaq:VCNX

VCNX Rankings

VCNX Stock Data

8.56M
591.10k
6.76%
41.7%
0.44%
Research and Development in Biotechnology
Professional, Scientific, and Technical Services
Link
United States of America
ROCHESTER

About VCNX

located in rochester, ny, vaccinex is a privately held, clinical-stage biotechnology company engaged in the discovery and development of human therapeutic monoclonal antibodies, therapeutic vaccines and other biologic products to treat serious diseases with unmet needs, including cancer, multiple sclerosis, and other autoimmune diseases. we conduct discovery research in-house and in collaboration with world-class academic institutions and biotechnology companies, and have an experienced in-house drug development management team to advance our pre-clinical and clinical stage biopharmaceutical development programs. our development team is led by seasoned industry veterans with both operational and executive level biopharmaceutical industry experience in therapeutic biologics research, manufacturing, quality assurance, quality control, toxicology, pharmacology, drug regulatory affairs, and clinical affairs. we are committed to innovation in the way we approach drug discovery and develop